Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Deerfield Management Company

Latest statistics and disclosures from Deerfield Management Company's latest quarterly 13F-HR filing:

Top 5 stock holdings are NUVL, Brookdale Sr Living, RVMD, PRAX, VTRS, and represent 39.72% of Deerfield Management Company's stock portfolio.
Added to shares of these 10 stocks: Revolution Medicines (+$252M), GMAB (+$121M), Celcuity (+$114M), MLYS (+$107M), BSX (+$56M), Parabilis Medicines (+$52M), IDYA (+$44M), BMRN (+$28M), Avalyn Pharma (+$24M), Odyssey Therapeutics (+$20M).
Started 13 new stock positions in Revolution Medicines, Celcuity, Hemab Therapeutics Holdings, Parabilis Medicines, MIRM, Avalyn Pharma, BSX, ADAG, Mobia Med, CHE. Odyssey Therapeutics, MLYS, Alamar Biosciences.
Reduced shares in these 10 stocks: Mirum Pharmaceuticals Inc Note 4.000 5/0 (-$209M), COGT (-$156M), , , DAWN (-$80M), Enhabit Ord (-$67M), CNC (-$65M), INSP (-$63M), INDV (-$59M), Neogenomics (-$56M).
Sold out of its positions in PHGE, CPRX, CMPX, CGEM, DAWN, Enhabit Ord, KYMR, Mirum Pharmaceuticals Inc Note 4.000 5/0, MYGN, NBIX. Quantum Si, TSHA, MANE.
Deerfield Management Company was a net seller of stock by $-146M.
Deerfield Management Company has $9.6B in assets under management (AUM), dropping by 13.09%.
Central Index Key (CIK): 0001009258

Tip: Access up to 7 years of quarterly data

Positions held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Deerfield Management Company

Deerfield Management Company holds 82 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Nuvalent Inc-a (NUVL)	22.2	$2.1B		17M	123.50	View chart
Brookdale Sr Living Note 3.500%10/1 (Principal)	6.1	$586M		307M	1.91	View chart
Revolution Medicines (RVMD)	4.7	$448M	+4%	2.4M	187.28	View chart
Praxis Precision Medicines I Com New (PRAX)	3.4	$323M		963k	334.79	View chart
Viatris (VTRS)	3.3	$321M		20M	15.88	View chart
Centene Corporation (CNC)	3.3	$315M	-17%	4.9M	64.19	View chart
Revolution Medicines Note 0.500% 5/0 (Principal)	2.6	$252M	NEW	200M	1.26	View chart
United Therapeutics Corporation (UTHR)	2.6	$248M		457k	541.83	View chart
Arrowhead Pharmaceuticals In Note 1/1 (Principal)	2.5	$241M		200M	1.20	View chart
Legend Biotech Corp Sponsored Ads (LEGN)	2.5	$235M	+5%	8.1M	28.88	View chart
Cogent Biosciences (COGT)	2.0	$194M	-44%	5.0M	38.70	View chart
Genmab A/s Sponsored Ads (GMAB)	2.0	$189M	+178%	6.9M	27.47	View chart
Brookdale Senior Living (BKD)	2.0	$187M		12M	16.09	View chart
Vera Therapeutics Cl A (VERA)	1.8	$168M	+5%	3.9M	42.91	View chart
Ionis Pharmaceuticals (IONS)	1.6	$157M		2.0M	79.29	View chart
Celcuity (CELC)	1.6	$152M	-15%	1.5M	104.62	View chart
BioCryst Pharmaceuticals (BCRX)	1.6	$151M		15M	10.00	View chart
Newamsterdam Pharma Company Ordinary Shares (NAMS)	1.5	$145M		4.3M	33.89	View chart
Acadia Healthcare (ACHC)	1.4	$134M		4.5M	29.53	View chart
Tango Therapeutics (TNGX)	1.4	$131M		4.2M	31.26	View chart
Adapthealth Corp Common Stock (AHCO)	1.2	$120M		12M	10.42	View chart
Pharvaris N V (PHVS)	1.2	$117M	+7%	3.4M	34.58	View chart
Celcuity Note 0.250% 8/0 (Principal)	1.2	$114M	NEW	100M	1.14	View chart
Arrowhead Pharmaceuticals (ARWR)	1.2	$113M	-11%	1.4M	81.51	View chart
Dianthus Therapeutics (DNTH)	1.1	$110M	+10%	1.1M	97.48	View chart
Larimar Therapeutics (LRMR)	1.1	$109M		36M	3.05	View chart
Mineralys Therapeutics (MLYS)	1.1	$107M	NEW	4.0M	26.98	View chart
Alignment Healthcare Note 4.250%11/1 (Principal)	1.1	$104M		61M	1.70	View chart
Ideaya Biosciences (IDYA)	1.1	$101M	+77%	2.7M	37.27	View chart
Xenon Pharmaceuticals (XENE)	1.0	$98M		1.6M	60.36	View chart
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)	1.0	$93M		60M	1.55	View chart
Savara (SVRA)	0.9	$84M		14M	6.16	View chart
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)	0.9	$84M	-9%	753k	110.94	View chart
Syndax Pharmaceuticals (SNDX)	0.9	$83M		3.8M	21.86	View chart
Zenas Biopharma Note 2.500% 4/0 (Principal)	0.8	$80M	+3%	67M	1.20	View chart
BioMarin Pharmaceutical (BMRN)	0.8	$76M	+56%	1.3M	57.22	View chart
Pfizer (PFE)	0.8	$73M		3.0M	24.08	View chart
Indivior Pharmaceuticals (INDV)	0.7	$68M	-46%	1.6M	41.03	View chart
Bio Rad Labs Cl A (BIO)	0.7	$66M		226k	293.61	View chart
Silverback Therapeutics (SPRY)	0.6	$60M		7.5M	8.01	View chart
Stoke Therapeutics (STOK)	0.6	$60M		1.8M	32.72	View chart
Structure Therapeutics Sponsored Ads (GPCR)	0.6	$58M	+41%	1.1M	53.67	View chart
Envista Hldgs Corp (NVST)	0.6	$58M		2.2M	26.35	View chart
Inspire Med Sys (INSP)	0.6	$58M	-52%	1.3M	44.61	View chart
Caredx (CDNA)	0.6	$57M	-8%	2.0M	28.50	View chart
Boston Scientific Corporation (BSX)	0.6	$56M	NEW	1.3M	42.68	View chart
Belite Bio Sponsored Ads (BLTE)	0.6	$55M	+17%	357k	153.99	View chart
Parabilis Medicines	0.5	$52M	NEW	1.9M	27.37	View chart
Certara Ord (CERT)	0.5	$49M	-3%	7.5M	6.55	View chart
Disc Medicine (IRON)	0.5	$48M		657k	73.14	View chart
Livanova Note 2.500% 3/1 (Principal)	0.5	$47M		34M	1.36	View chart
Bridgebio Oncology Therapeut Com New (BBOT)	0.4	$37M		4.9M	7.62	View chart
Tyra Biosciences (TYRA)	0.3	$33M	+85%	1.0M	31.94	View chart
Monopar Therapeutics Com New (MNPR)	0.3	$30M		324k	92.59	View chart
Sionna Therapeutics (SION)	0.3	$30M	-29%	681k	43.99	View chart
Immunocore Hldgs Note 2.500% 2/0 (Principal)	0.3	$27M		30M	0.90	View chart
Avalyn Pharmaceuticals Com Shs	0.3	$24M	NEW	731k	32.92	View chart
Foghorn Therapeutics (FHTX)	0.2	$21M		4.4M	4.88	View chart
Beta Bionics (BBNX)	0.2	$21M		1.3M	15.67	View chart
Alnylam Pharmaceuticals (ALNY)	0.2	$21M		68k	301.03	View chart
Bright Minds Biosciences Com New (DRUG)	0.2	$20M		283k	70.20	View chart
Odyssey Therapeutics Common Stock	0.2	$20M	NEW	1.0M	18.71	View chart
Oncology Institu (TOI)	0.2	$18M		3.4M	5.43	View chart
Kyverna Therapeutics (KYTX)	0.2	$18M		2.0M	8.91	View chart
Alamar Biosciences Common Stock	0.2	$16M	NEW	600k	27.09	View chart
Chemed Corp Com Stk (CHE)	0.1	$14M	NEW	30k	465.74	View chart
Spyglass Pharma Com Shs (SGP)	0.1	$12M		550k	22.26	View chart
Neogenomics Note 0.250% 1/1 (Principal)	0.1	$12M	-82%	13M	0.94	View chart
Adagene Ads (ADAG)	0.1	$11M	NEW	2.7M	4.20	View chart
Hemab Therapeutics Hldgs Com Shs	0.1	$10M	NEW	275k	36.73	View chart
Mobia Med Common Stock	0.1	$9.0M	NEW	671k	13.40	View chart
Embecta Corp Common Stock (EMBC)	0.1	$8.3M		2.5M	3.26	View chart
Veracyte (VCYT)	0.1	$5.9M	-86%	101k	58.73	View chart
Annexon (ANNX)	0.0	$3.3M		584k	5.71	View chart
Alector (ALEC)	0.0	$2.1M		1.1M	2.01	View chart
Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW)	0.0	$2.0M		93k	21.37	View chart
Edwards Lifesciences (EW)	0.0	$1.2M		14k	90.46	View chart
Mirum Pharmaceuticals (MIRM)	0.0	$706k	NEW	6.0k	117.07	View chart
Humana (HUM)	0.0	$364k		917.00	397.22	View chart
The Oncology Institute *w Exp 99/99/999 (TOIIW)	0.0	$51k		1.3M	0.04	View chart
Pmv Pharmaceuticals (PMVP)	0.0	$12k		8.8k	1.34	View chart
Surrozen *w Exp 08/01/203 (SRZNW)	0.0	$2.7k		167k	0.02	View chart

Past Filings by Deerfield Management Company

SEC 13F filings are viewable for Deerfield Management Company going back to 2010

Deerfield Management Company 2026 Q2 filed Aug. 14, 2026
Deerfield Management Company 2026 Q1 filed May 15, 2026
Deerfield Management Company 2025 Q4 filed Feb. 17, 2026
Deerfield Management Company 2025 Q3 filed Nov. 14, 2025
Deerfield Management Company 2025 Q2 filed Aug. 14, 2025
Deerfield Management Company 2025 Q1 filed May 15, 2025
Deerfield Management Company 2024 Q4 filed Feb. 14, 2025
Deerfield Management Company 2024 Q3 filed Nov. 14, 2024
Deerfield Management Company 2024 Q2 filed Aug. 14, 2024
Deerfield Management Company 2024 Q1 filed May 15, 2024
Deerfield Management Company 2023 Q4 filed Feb. 14, 2024
Deerfield Management Company 2023 Q3 filed Nov. 14, 2023
Deerfield Management Company 2023 Q2 filed Aug. 14, 2023
Deerfield Management Company 2023 Q1 filed May 15, 2023
Deerfield Management Company 2022 Q4 filed Feb. 14, 2023
Deerfield Management Company 2022 Q3 filed Nov. 14, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z